Core Viewpoint - The company has announced its 2024 annual profit distribution plan, which includes a cash dividend of 0.92 RMB per 10 shares, totaling approximately 33 million RMB, with no stock bonus or capital reserve conversion [1][2]. Profit Distribution Plan - The profit distribution plan is based on a total share capital of 358,745,103 shares as of April 22, 2025, with a cash dividend of 0.92 RMB per 10 shares, amounting to a total cash distribution of 33,004,549.48 RMB [1]. - The total share capital will increase to 380,791,304 shares after the conversion of convertible bonds during the distribution period [1]. Dividend Taxation - The cash dividend will be subject to different tax rates based on the type of shareholder, with specific provisions for Hong Kong investors and domestic investors [2]. - The company will not withhold individual income tax at the time of distribution; instead, it will be calculated based on the holding period when shares are sold [2]. Key Dates - The record date for the profit distribution is set for May 22, 2025, and the ex-dividend date is May 23, 2025 [2]. Distribution Recipients - The distribution will be made to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shenzhen Branch as of the record date [3]. Adjustment of Parameters - Following the distribution, the minimum selling price promised by shareholders in the IPO prospectus will be adjusted accordingly [3]. - The conversion price of the convertible bonds will be adjusted from 21.89 RMB per share to 21.80 RMB per share [4].

回转支承专业制造 债券代码：123161 债券简称：强联转债 证券代码：300850 证券简称：新强联 公告编号：2025-035 1、债券简称：强联转债，债券代码：123161； 2、本次调整前转股价格：21.89 元/股； 3、本次调整后转股价格：21.80 元/股； 4、转股价格调整生效日期：2025 年 5 月 23 日。 一、关于可转换公司债券转股价格调整的相关规定 经中国证券监督管理委员会《关于同意洛阳新强联回转支承股份有限公司向不特定 对象发行可转换公司债券注册的批复》（证监许可〔2022〕2158 号）核准，洛阳新强联 回转支承股份有限公司（以下简称"公司"）于 2022 年 10 月 11 日向不特定对象发行 可转换公司债券 1,210.00 万张，每张面值为人民币 100 元，发行总额为人民币 121,00 0.00 万元。本次发行可转换公司债券的上市时间为 2022 年 10 月 27 日，债券简称为"强 联转债"、债券代码为"123161"。 洛阳新强联回转支承股份有限公司 关于"强联转债"转股价格调整的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误 ...

回转支承专业制造 证券代码：300850 证券简称：新强联 公告编号：2025-034 债券代码：123161 债券简称：强联转债 一、股东大会审议通过的利润分配方案情况 1、公司于 2025 年 5 月 14 日召开 2024 年年度股东大会，审议通过了《关于公司 2024 年度利润分配预案的议案》。公司 2024 年年度利润分配方案为： 以公司截至 2025 年 4 月 22 日总股本 358,745,103 股为基数，向全体股东每 10 股 派发现金红利 0.92 元（含税），合计派发现金红利人民币 33,004,549.48 元（含税）， 不送红股，不进行资本公积金转增股本，剩余未分配利润结转以后年度。如权益分派股 权登记日前公司股本发生变动的，将按照分配比例不变的原则对分配总额进行调整。 2、自上述分配方案披露至实施期间公司股本总额的变化：上述预案公布后，公司 可转换公司债券（债券简称：强联转债；债券代码：123161）正处于转股期，自 2025 年 4 月 23 日至 2025 年 5 月 14 日，转股数量为 22,046,201 股，公司总股本由 358,745,103 股增加至 380,79 ...

Group 1: Company Performance and Market Demand - The company expects strong performance in Q2 2025 due to sufficient production orders and robust downstream customer demand [2] - The overall gross margin is influenced by market competition, capacity utilization, and the supporting industrial chain [2] - The company has established long-term partnerships with several domestic wind power manufacturers, reflecting its market penetration strategy [2] Group 2: Production and Efficiency Enhancements - The company is maximizing capacity to meet downstream market demands through increased R&D, equipment upgrades, process improvements, and workforce expansion [3] - Various heat treatment processes are utilized, tailored to customer requirements, product characteristics, application scenarios, and processing costs [3] Group 3: Compliance and Transparency - The investor relations activity adhered to regulations, ensuring participants signed a research commitment letter, and the company guarantees truthful, accurate, complete, timely, and fair information disclosure [3]

上海市广发律师事务所 关于洛阳新强联回转支承股份有限公司 2024 年年度股东大会的 法律意见书 电话：021-58358013 | 传真：021-58358012 网址：http://www.gffirm.com | 电子信箱：gf@gffirm.com 办公地址：上海市浦东新区南泉北路 429 号泰康大厦 26 楼 | 邮政编码：200120 上海市广发律师事务所 关于洛阳新强联回转支承股份有限公司 2024 年年度股东大会的法律意见书 致：洛阳新强联回转支承股份有限公司 洛阳新强联回转支承股份有限公司（以下简称"公司"）2024 年年度股东大 会于 2025 年 5 月 14 日在河南省洛阳市新安县新安经济技术开发区洛新园区京津 路 8 号 4 楼会议室召开。上海市广发律师事务所经公司聘请，委派藕淏律师、陈 雨兰律师出席现场会议，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律法规、其他规范性 文件以及《洛阳新强联回转支承股份有限公司章程》（以下简称"《公司章程》"） 的规定，就本次股东大会的召集和召开程序、召集人及出席会议人员的资格、 ...

回转支承专业制造 2.本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 证券代码：300850 证券简称：新强联 公告编号：2025-033 债券代码：123161 债券简称：强联转债 洛阳新强联回转支承股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会没有否决议案的情形。 （1）现场会议：2025 年 5 月 14 日（星期三）下午 14:30。 （2）网络投票：通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 14 日上午 9:15-9:25，9:30-11:30，下午 13:00-15:00；通过深圳证券交易所互 联网投票系统进行网络投票的具体时间为：2025 年 5 月 14 日 9:15-15:00。 2、现场会议地点：河南省洛阳市新安县经济技术开发区洛新园区京津路 8 号 4 楼 会议室。 3、会议的召开方式：本次股东大会采用现场表决与网络投票相结合的方式。 4、会议召集人：公司第四届董事 ...

Group 1: 华峰化学 - Company decided to terminate the acquisition of 100% equity in Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. due to insufficient shareholder approval [1] - The decision was made based on prudence, as the proposal did not receive more than two-thirds of the valid voting rights at the shareholders' meeting [1] - Company will continue to promote related equity injection work and strictly fulfill asset injection commitments [1] Group 2: 中荣股份 - Actual controller and chairman Huang Huanran has been placed under residential surveillance by the police [2] - Other board members and senior management are performing their duties normally, and the board of directors is operating as usual [2] - Company specializes in the research, design, production, and sales of paper printing and packaging products [2] Group 3: 密尔克卫 - Three shareholders plan to reduce their holdings by a total of up to 2% of the company's shares through block trading [3] - The reduction includes 143.63 million shares, 97.65 million shares, and 75.03 million shares, representing 0.91%, 0.62%, and 0.47% of the total share capital respectively [3] - The reduction period is from June 6, 2025, to September 5, 2025, due to personal funding needs [3] Group 4: 舒泰神 - Subsidiary Jiangsu Beijietai Biotechnology Co., Ltd. has obtained a drug production license from the Jiangsu Provincial Drug Administration [4] - The license allows for the production of therapeutic biological products, specifically for registered declaration use [4] - The license is valid until May 7, 2030, and is not expected to have a significant impact on the company's current performance [4] Group 5: 捷顺科技 - Company won the bid for the "Chongqing Beautiful Sunshine Home and other public rental housing supporting parking space operation project" [5] - The project includes four public rental housing supporting parking lots with a total of 13,335 parking spaces [5] - The minimum guaranteed revenue for the project is quoted at 40.43 million yuan per year, with a total contract amount expected to exceed 100 million yuan [5] Group 6: 综艺股份 - Company signed an investment cooperation intention agreement to acquire control of Jiangsu Jilai Microelectronics Co., Ltd. through cash capital increase or share transfer [6] - Jilai Micro primarily engages in the research, production, and sales of power semiconductor chips and devices [6] - The transaction is expected to constitute a major asset restructuring [6] Group 7: 东山精密 - Subsidiary DSBJ PTE. LTD. plans to acquire 100% equity of French GMD Group for approximately 100 million euros (about 814 million yuan) [7] - The acquisition aims to advance the company's globalization strategy and enhance its market share in the automotive parts sector [7] - The company specializes in the research, production, and sales of electronic circuit products and precision components [7] Group 8: 诺诚健华 - Company reported a net profit of 17.97 million yuan for the first quarter of 2025, a significant turnaround from a loss of 142 million yuan in the same period last year [8] - The first quarter revenue reached 381 million yuan, representing a year-on-year growth of 129.92% [8] - The company focuses on the research, production, and commercialization of innovative drugs [8] Group 9: 凯美特气 - Shareholders plan to reduce their holdings by up to 3% of the company's shares through centralized bidding and/or block trading [9] - The total number of shares to be reduced is 20.86 million [9] - The reduction is due to personal funding needs [9] Group 10: 海创药业 - Controlling shareholder plans to reduce holdings by up to 2% of the company's shares through centralized bidding and block trading [10] - The total number of shares to be reduced is 1.98 million [10] - The reduction is due to personal funding needs [10] Group 11: 高争民爆 - Controlling shareholder plans to reduce holdings by up to 3% of the company's shares through centralized bidding and block trading [11] - The total number of shares to be reduced is 828,000 [11] - The reduction is due to the company's funding needs [11] Group 12: 金埔园林 - Two shareholders plan to reduce their holdings by a total of up to 1.91% of the company's shares [12] - The reductions include 183.93 million shares and 167.73 million shares [12] - The reasons for the reductions are asset optimization and personal funding needs [12] Group 13: 掌趣科技 - The largest shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding or block trading [13] - The total number of shares to be reduced is 27.2 million [13] - The reduction is due to personal funding needs [13] Group 14: 美凯龙 - Company announced that its director and general manager has been placed under investigation and detention by the local supervisory committee [14] - Other board members and senior management are performing their duties normally, and daily operations are unaffected [14] - The company specializes in managing and operating self-operated and franchised shopping malls [14] Group 15: 新强联 - Major shareholder plans to reduce holdings by up to 1.89% of the company's shares through centralized bidding and block trading [15] - The total number of shares to be reduced is 717,490 [15] - The reduction is due to operational needs [15] Group 16: 日月明 - Shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding [16] - The total number of shares to be reduced is 80,000 [16] - The reduction is due to personal funding needs [16] Group 17: 同有科技 - Major shareholder and vice president plan to reduce their holdings by up to 1.53% of the company's shares [17] - The total number of shares to be reduced is 730,850 [17] - The reduction is due to personal funding needs [17] Group 18: 爱尔眼科 - Subsidiary successfully acquired 60% equity and specific debt of Shenzhen Guangsheng Digital Technology Co., Ltd. for 650 million yuan [18] - The transaction constitutes a related party transaction [18] - The acquired asset will serve as long-term medical premises for the subsidiary [18]

Group 1 - Shareholders of Jinpu Garden plan to reduce their holdings by no more than 1.91% of the company's shares [1] - Shareholders of Xinqianglian plan to reduce their holdings by no more than 1.89% of the company's shares [1] - Hengbang shares received a regulatory letter for failing to disclose information in a timely manner [1] Group 2 - The Snowy Yong convertible bond and the Qianglian convertible bond will not be forcibly redeemed [1]

新强联（300850）公告，持股5%以上股东海通开元计划在2025年6月5日至2025年9月4日期间，以集中 竞价和大宗交易方式减持不超过358.74万股，占公司总股本比例0.95%。 ...

回转支承专业制造 洛阳新强联回转支承股份有限公司 关于持股 5%以上股东减持股份预披露公告 大股东海通开元投资有限公司保证向本公司提供的信息内容真 实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 特别提示： 持有洛阳新强联回转支承股份有限公司（以下简称"新强联"或"公司"）股份 2 2,912,097 股（占公司总股本比例 6.04%，以截至 2025 年 5 月 12 日的总股本 379,175, 746 股计算，下同）的大股东海通开元投资有限公司（以下简称"海通开元"）计划在 自本公告披露之日起 15 个交易日后的三个月内（2025 年 6 月 5 日至 2025 年 9 月 4 日） 以集中竞价方式减持本公司股份不超过 3,587,447 股（占公司总股本比例 0.95%）、以 大宗交易方式减持公司股份不超过 3,587,447 股（占公司总股本比例 0.95%）。 证券代码：300850 证券简称：新强联 公告编号：2025-032 债券代码：123161 债券简称：强联转债 （一）本次减持计划基本内容 1、本次拟减持的原因： ...